Medicare Advantage enrollment growth slowed sharply in early 2026, breaking a years-long streak of rapid expansion that had drawn tens of millions of seniors into privately run plans. Federal enrollment data for February 2026 shows growth slowed year over year, with gains appearing to be driven more by Special Needs Plans than broad-based increases. The deceleration arrives at an awkward moment: insurers cut premiums and the government projected a payment increase, yet plan discontinuations meant many beneficiaries had to find new coverage.
Why Growth Stalled Despite a Payment Increase
The numbers tell a split story. CMS finalized 2026 payment policies that included a projected payment increase for Medicare Advantage plans, with major drivers including the effective growth rate and adjustments to risk model normalization elements, according to the 2026 rate announcement. Average monthly premiums fell from $15.76 in 2025 to $10.62 in 2026, per a CMS fact sheet released in September 2025. On paper, that combination of higher federal payments and lower consumer costs should have accelerated sign-ups.
Instead, the February enrollment tables show year-over-year growth that falls well below the double-digit percentage gains the program posted in earlier years. One factor cited by insurers: expectations of higher medical cost trends. For example, UnitedHealth Group pointed to elevated cost trends in its second-quarter 2025 results. That caution may have contributed to some carriers tightening benefits or exiting certain markets rather than prioritizing membership growth. The 2026 Part C and D Plan Crosswalk files show many plans were discontinued or mapped to successor offerings, underscoring how a seemingly favorable payment environment still translated into retrenchment on the ground.
Plan Exits Hit Small Carriers and Their Enrollees Hardest
CMS characterized the Medicare Advantage and Medicare Prescription Drug market as stable for 2026. That framing clashes with findings from Johns Hopkins Bloomberg School of Public Health, which reported that 1 in 10 Medicare Advantage enrollees faced forced disenrollment in 2026. According to that analysis, people losing their plans were more likely to be enrolled in plans offered by small insurance carriers and more likely to be living in certain geographic areas. The gap between the government’s “stable” label and the scale of involuntary disruption reflects a market where large parent organizations like UnitedHealth Group held steady while smaller competitors shed members or exited entirely.
For affected beneficiaries, the practical fallout is significant. Forced disenrollment means choosing a new plan during a special enrollment period or defaulting back to traditional Medicare, often with little time to compare provider networks, drug formularies, or out-of-pocket limits. CMS directs enrollees to use online comparison tools during shopping windows, but the number of plan discontinuations and changes in 2026 can make that process harder than in prior years. Seniors who relied on supplemental benefits unique to their discontinued plan, such as dental, vision, or transportation services, may find that replacement options in their county offer narrower packages, even as headline premiums remain low.
What the Slowdown Signals for the Program’s Future
The conventional reading of Medicare Advantage has been a straight growth story, with enrollment climbing as plans layered on extra benefits and zero-premium options. The 2026 slowdown complicates that narrative, suggesting the program may be entering a more mature phase where growth is constrained by medical cost trends, regulatory guardrails, and the willingness of insurers to tolerate thinner margins. The fact that Special Needs Plans continued to expand while more standard products stalled hints at a shift toward serving higher-need, higher-acuity populations who generate more predictable revenue under risk-adjusted payment formulas.
For policymakers, the experience of 2026 raises questions about how to balance stability and competition. Labeling the market stable while millions endure plan terminations risks eroding trust, particularly among beneficiaries who do not distinguish between a parent company’s continued participation and the disappearance of their specific plan. At the same time, allowing unprofitable products to exit may prevent more abrupt disruptions later if financial pressures mount. Beneficiaries still retain the backstop of traditional Medicare, with core information and enrollment resources housed on the main Medicare website, but shifting from an integrated Medicare Advantage product back to fee-for-service coverage can mean losing bundled supplemental benefits and navigating Medigap underwriting rules in some states.
Looking ahead, the 2026 enrollment pattern is likely to influence how insurers price and design 2027 offerings. If medical costs continue to rise faster than expected, plans may further narrow networks, trim extras, or introduce more utilization management to protect margins, potentially making Medicare Advantage less attractive at the margins despite relatively low premiums. Conversely, if cost trends moderate, carriers could reintroduce richer benefits to regain momentum, but they may do so more cautiously after a year in which aggressive growth strategies looked riskier. For beneficiaries and advocates, the lesson is to treat Medicare Advantage not as a static product but as a dynamic market that can change meaningfully from one year to the next, making careful annual review of plan options less a best practice than a necessity.
More From The Daily Overview
*This article was researched with the help of AI, with human editors creating the final content.
Nathaniel Cross focuses on retirement planning, employer benefits, and long-term income security. His writing covers pensions, social programs, investment vehicles, and strategies designed to protect financial independence later in life. At The Daily Overview, Nathaniel provides practical insight to help readers plan with confidence and foresight.
